In Silico medicine in FP9

05 Sep 2018
17:00-18:30

In Silico medicine in FP9

    • 16:30 – 16:40: Lies Geris – VPHi Executive Director: “The VPH Institute: promoting in silico medicine research” and “the VPHi FP9 Position Paper”

 

    • 16:40 – 17:00: Violeta Isabel Pérez Nueno (Programme Officer in charge of the in silico portfolio at Unit 3 – eHealth, Well-being & Ageing, DG CONNECT: “Future priorities of in-silico medicine”

 

    • 17:00 – 17:20: Tina Morrison (FDA): FDA research priorities for in silico medicine

 

  • 17:20 – 17:30: Q&A